I’m an economics professor at BI Norwegian Business School, interested in how competition and regulation shape public service provision and healthcare, with a particular focus on pharmaceutical markets.  Every year I introduce new business students to the fascinating world of economics. Some see the fascination, others don’t.

I have published in journals such as The Economic Journal, European Economic Review, Journal of Economics and Management Strategy and Journal of Health Economics.

In 1984, Ronald Reagan signed a law that changed pharmaceutical companies ability to protect themselves from competition. Forty years later, the consequences show up every time you visit a pharmacy. Blåkopi – a book I am currently writing – will tell the story of that law, and what competition in pharmaceutical markets actually delivers, and to whom.

Since 2015, I have served on the Board of Directors of Nye Veier, a state-owned company responsible for planning and building major road infrastructure in Norway.

From 2010 to 2018, I was provost at BI, overseeing program quality, accreditation and international cooperation. I currently serve on the International Advisory Council of TIAS School for Business and Society in the Netherlands.

I am a partner in Vista Analyse, a social science consultancy in Oslo.